Unit
Endokrinologie | Diabetologie | Osteologie | Stoffwechselerkrankungen
ENDO · Dept. I
[A rare side effect of antithyroid drug therapy].
Büchel-Boekstegers A, Koster M, Lieberherr S, Cozzio A, Bilz S. [A rare side effect of antithyroid drug therapy]. Praxis (Bern 1994) 2024; 113:245-248.
Oct 1, 2024[A rare side effect of antithyroid drug therapy].
Oct 1, 2024Praxis (Bern 1994) 2024; 113:245-248
Büchel-Boekstegers Armgard, Koster Markus, Lieberherr Sven, Cozzio Antonio, Bilz Stefan
Tracking Real-World Physical Activity in Chronic Obstructive Pulmonary Disease Over One Year: Results from a Monocentric, Prospective, Observational Cohort Study.
Bösch M, Baty F, Bilz S, Brutsche M, Rassouli F. Tracking Real-World Physical Activity in Chronic Obstructive Pulmonary Disease Over One Year: Results from a Monocentric, Prospective, Observational Cohort Study. Int J Chron Obstruct Pulmon Dis 2024; 19:1921-1929.
Aug 27, 2024Tracking Real-World Physical Activity in Chronic Obstructive Pulmonary Disease Over One Year: Results from a Monocentric, Prospective, Observational Cohort Study.
Aug 27, 2024Int J Chron Obstruct Pulmon Dis 2024; 19:1921-1929
Bösch Maximilian, Baty Florent, Bilz Stefan, Brutsche Martin, Rassouli Frank
Pulmonary and Systemic Hemodynamics in Patients with Hyperthyroidism.
Brenner R, Drescher T, Locher R, Bilz S, Rickli H, Brändle M, Nobel D, Weilenmann D, Ammann P, Maeder M. Pulmonary and Systemic Hemodynamics in Patients with Hyperthyroidism. Am J Med 2023
Dec 15, 2023Pulmonary and Systemic Hemodynamics in Patients with Hyperthyroidism.
Dec 15, 2023Am J Med 2023
Brenner Roman, Drescher Tilman, Locher Rebecca, Bilz Stefan, Rickli Hans, Brändle Michael, Nobel Daniel, Weilenmann Daniel, Ammann Peter, Maeder Micha
[Lipid Management in Practice].
Dehos B, Bilz S. [Lipid Management in Practice]. Praxis (Bern 1994) 2023; 112:649-654.
Dec 1, 2023[Lipid Management in Practice].
Dec 1, 2023Praxis (Bern 1994) 2023; 112:649-654
Dehos Barbara, Bilz Stefan
An estimation of the consequences of reinforcing the 2016 and 2019 European Society of Cardiology/European Atherosclerosis Society guidelines on current lipid-lowering treatment in patients with type 2 diabetes in tertiary care-a SwissDiab study.
Singeisen H, Renström F, Laimer M, Lehmann R, Bilz S, Brändle M. An estimation of the consequences of reinforcing the 2016 and 2019 European Society of Cardiology/European Atherosclerosis Society guidelines on current lipid-lowering treatment in patients with type 2 diabetes in tertiary care-a SwissDiab study. Eur J Prev Cardiol 2023; 30:1473-1481.
Oct 10, 2023An estimation of the consequences of reinforcing the 2016 and 2019 European Society of Cardiology/European Atherosclerosis Society guidelines on current lipid-lowering treatment in patients with type 2 diabetes in tertiary care-a SwissDiab study.
Oct 10, 2023Eur J Prev Cardiol 2023; 30:1473-1481
Singeisen Hélène, Renström Frida, Laimer Markus, Lehmann Roger, Bilz Stefan, Brändle Michael
Safety Outcomes of Impact Microindentation: A Prospective Observational Study in the Netherlands.
Schöb M, Avci T, Winter E, Appelman-Dijkstra N. Safety Outcomes of Impact Microindentation: A Prospective Observational Study in the Netherlands. JBMR Plus 2023; 7:e10799.
Jul 21, 2023Safety Outcomes of Impact Microindentation: A Prospective Observational Study in the Netherlands.
Jul 21, 2023JBMR Plus 2023; 7:e10799
Schöb Manuela, Avci Telli M, Winter Elizabeth M, Appelman-Dijkstra Natasha M
Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay.
Jaun F, Boesing M, Lüthi-Corridori G, Abig K, Bloch N, Giezendanner S, Grillmayr V, Haas P, Leuppi-Taegtmeyer A, Muser J, Räss A, Schuetz P, Brändle M, Leuppi J. Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay. Biomedicines 2023; 11
Apr 25, 2023Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay.
Apr 25, 2023Biomedicines 2023; 11
Jaun Fabienne, Boesing Maria, Lüthi-Corridori Giorgia, Abig Kristin, Bloch Nando, Giezendanner Stéphanie, Grillmayr Victoria, Haas Philippe, Leuppi-Taegtmeyer Anne Barbara, Muser Jürgen, Räss Andrea, Schuetz Philipp, Brändle Michael, Leuppi Joerg Daniel
Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland: A health-economic analysis.
Tzogiou C, Wieser S, Eichler K, Carlander M, Djalali S, Rosemann T, Brändle M. Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland: A health-economic analysis. J Diabetes Complications 2023; 37:108476.
Apr 23, 2023Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland: A health-economic analysis.
Apr 23, 2023J Diabetes Complications 2023; 37:108476
Tzogiou Christina, Wieser Simon, Eichler Klaus, Carlander Maria, Djalali Sima, Rosemann Thomas, Brändle Michael
Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial.
Komminoth M, Donath M, Hepprich M, Schuetz P, Blum C, Müller-Stich B, Reny J, Gosselin P, Breville G, Brändle M, Henzen C, Leuppi J, Kistler A, Thurnheer R, Beuschlein F, Rudofsky G, Aeberli D, Villiger P, Böhm S, Chifu I, Fassnacht M, Meyer G, Bojunga J, Cattaneo M, Sluka C, Schneider H, Rutishauser J, «TOASST» study group. Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial. PloS one 2023; 18:e0281585.
Apr 5, 2023Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial.
Apr 5, 2023PloS one 2023; 18:e0281585
Komminoth Mathis, Donath Marc Y, Hepprich Matthias, Schuetz Philipp, Blum Claudine A, Müller-Stich Beat P, Reny Jean-Luc, Gosselin Pauline, Breville Gautier, Brändle Michael, Henzen Christophe, Leuppi Joerg Daniel, Kistler Andreas D, Thurnheer Robert, Beuschlein Felix, Rudofsky Gottfried, Aeberli Daniel, Villiger Peter M, Böhm Stephan, Chifu Irina, Fassnacht Martin, Meyer Gesine, Bojunga Jörg, Cattaneo Marco, Sluka Constantin, Schneider Helga, Rutishauser Jonas, «TOASST» study group
Swiss recommendations of the Society for Endocrinology and Diabetes (SGED/SSED) for the treatment of type 2 diabetes mellitus (2023).
Gastaldi G, Lucchini B, Thalmann S, Alder S, Laimer M, Brändle M, Wiesli P, Lehmann R, Working group of the SGED/SSED. Swiss recommendations of the Society for Endocrinology and Diabetes (SGED/SSED) for the treatment of type 2 diabetes mellitus (2023). Swiss Med Wkly 2023; 153:40060.
Apr 1, 2023Swiss recommendations of the Society for Endocrinology and Diabetes (SGED/SSED) for the treatment of type 2 diabetes mellitus (2023).
Apr 1, 2023Swiss Med Wkly 2023; 153:40060
Gastaldi Giacomo, Lucchini Barbara Stella, Thalmann Sebastien, Alder Stephanie, Laimer Markus, Brändle Michael, Wiesli Peter, Lehmann Roger, Working group of the SGED/SSED
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.
Jensen A, Renström F, Aczel S, Folie P, Biraima M, Beuschlein F, Bilz S. Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study. Obes Surg 2023:1-9.
Feb 11, 2023Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.
Feb 11, 2023Obes Surg 2023:1-9
Jensen Anders Boisen, Renström Frida, Aczel Stefan, Folie Patrick, Biraima Magdalena, Beuschlein Felix, Bilz Stefan
Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology.
Zanchi A, Jehle A, Lamine F, Vogt B, Czerlau C, Bilz S, Seeger H, de Seigneux S. Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology. Swiss Med Wkly 2023; 153:40004.
Jan 6, 2023Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology.
Jan 6, 2023Swiss Med Wkly 2023; 153:40004
Zanchi Anne, Jehle Andreas W, Lamine Faiza, Vogt Bruno, Czerlau Cecilia, Bilz Stefan, Seeger Harald, de Seigneux Sophie
Association of CT-based diagnosis of sarcopenia with prognosis and treatment response in patients at risk of malnutrition - A secondary analysis of the Effect of early nutritional support on Frailty, Functional Outcomes, and Recovery of malnourished medical inpatients Trial (EFFORT) trial.
Baumgartner A, Olpe T, Griot S, Mentil N, Staub N, Burn F, Schindera S, Kaegi-Braun N, Tribolet P, Hoess C, Pavlicek V, Bilz S, Sigrist S, Brändle M, Henzen C, Thomann R, Rutishauser J, Aujesky D, Rodondi N, Donzé J, Stanga Z, Müller-Stich B, Schuetz P. Association of CT-based diagnosis of sarcopenia with prognosis and treatment response in patients at risk of malnutrition - A secondary analysis of the Effect of early nutritional support on Frailty, Functional Outcomes, and Recovery of malnourished medical inpatients Trial (EFFORT) trial. Clin Nutr 2022; 42:199-207.
Dec 22, 2022Association of CT-based diagnosis of sarcopenia with prognosis and treatment response in patients at risk of malnutrition - A secondary analysis of the Effect of early nutritional support on Frailty, Functional Outcomes, and Recovery of malnourished medical inpatients Trial (EFFORT) trial.
Dec 22, 2022Clin Nutr 2022; 42:199-207
Baumgartner Annic, Olpe Tobias, Griot Stephanie, Mentil Nicole, Staub Nathalie, Burn Felice, Schindera Sebastian, Kaegi-Braun Nina, Tribolet Pascal, Hoess Claus, Pavlicek Vojtech, Bilz Stefan, Sigrist Sarah, Brändle Michael, Henzen Christophe, Thomann Robert, Rutishauser Jonas, Aujesky Drahomir, Rodondi Nicolas, Donzé Jacques, Stanga Zeno, Müller-Stich Beat P, Schuetz Philipp
Von-Hippel-Lindau-Erkrankung
Koster K, Rothermundt C, Binet F, Borovicka J, Bozinov O, Clerici T, Engeler D, Greiner J, Hader C, Heinimann K, Azzarello-Burri S, Lang C, Krull I, Stöckli S, Omlin A, Hundsberger T. Von-Hippel-Lindau-Erkrankung - Interdisziplinäre Betreuung und neue therapeutische Optionen. Swiss Med Forum 2022; 48:4-784-787.
Nov 30, 2022Von-Hippel-Lindau-Erkrankung
Nov 30, 2022Swiss Med Forum 2022; 48:4-784-787
Koster Kira-Lee, Rothermundt Christian, Binet Françoise-Isabelle, Borovicka Jan, Bozinov Oliver, Clerici Thomas, Engeler Daniel, Greiner J, Hader Claudia, Heinimann Karl, Azzarello-Burri Silvia, Lang Corina, Krull Ina, Stöckli Sandro, Omlin Aurelius, Hundsberger Thomas
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Boesing M, Abig K, Brändle M, Brutsche M, Burri E, Frye B, Giezendanner S, Grutters J, Haas P, Heisler J, Jaun F, Leuppi-Taegtmeyer A, Lüthi-Corridori G, Müller-Quernheim J, Nüesch R, Pohl W, Rassouli F, Leuppi J. Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial. Trials 2022; 23:790.
Sep 20, 2022Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Sep 20, 2022Trials 2022; 23:790
Boesing Maria, Abig Kristin, Brändle Michael, Brutsche Martin, Burri Emanuel, Frye BjöC, Giezendanner Stéphanie, Grutters Jan C, Haas Philippe, Heisler Justian, Jaun Fabienne, Leuppi-Taegtmeyer Anne Barbara, Lüthi-Corridori Giorgia, Müller-Quernheim Joachim, Nüesch Reto, Pohl Wolfgang, Rassouli Frank, Leuppi Jörg D
Hyperkalzämie – Diagnose, Abklärung und Therapie
Koster M, Brändle M. Hyperkalzämie – Diagnose, Abklärung und Therapie. Praxis 2022
Sep 14, 2022Hyperkalzämie – Diagnose, Abklärung und Therapie
Sep 14, 2022Praxis 2022
Koster Markus, Brändle Michael
[Hypercalcemia - Diagnosis and Management].
Koster M, Brändle M. [Hypercalcemia - Diagnosis and Management]. Praxis (Bern 1994) 2022; 111:675-681.
Sep 1, 2022[Hypercalcemia - Diagnosis and Management].
Sep 1, 2022Praxis (Bern 1994) 2022; 111:675-681
Koster Markus, Brändle Michael
Association of pre- and postoperative αKlotho levels with long-term remission after pituitary surgery for acromegaly.
Neidert M, Zeitlberger A, Leske H, Tschopp O, Sze L, Zwimpfer C, Wiesli P, Bellut D, Bernays R, Rushing E, Schmid C. Association of pre- and postoperative αKlotho levels with long-term remission after pituitary surgery for acromegaly. Sci Rep 2022; 12:14765.
Aug 30, 2022Association of pre- and postoperative αKlotho levels with long-term remission after pituitary surgery for acromegaly.
Aug 30, 2022Sci Rep 2022; 12:14765
Neidert Marian Christoph, Zeitlberger Anna Maria, Leske Henning, Tschopp Oliver, Sze Lisa, Zwimpfer Cornelia, Wiesli Peter, Bellut David, Bernays René-Ludwig, Rushing Elisabeth Jane, Schmid Christoph
Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma
Eugster P, Brown N, Hubers S, Schütze I, Reul A, Nölting S, Beuschlein F, Sigrist S, Bilz S, Kolb W, Henzen C, Fischli S, Trepp R, Wuerzner G, Matter M, Abid K, Vocat C, Maurer J, Grouzmann E. Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma. Clin Chim Acta 2022; 534:146-155.
Jul 26, 2022Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma
Jul 26, 2022Clin Chim Acta 2022; 534:146-155
Eugster Philippe J, Brown Nancy J, Hubers Scott A, Schütze Ina, Reul Astrid, Nölting Svenja, Beuschlein Felix, Sigrist Sarah, Bilz Stefan, Kolb Walter, Henzen Christoph, Fischli Stefan, Trepp Roman, Wuerzner Gregoire, Matter Maurice, Abid Karim, Vocat Céline, Maurer Jonathan, Grouzmann Eric
Evaluation of type 2 diabetes care management in nine primary care practices before and after implementation of the Criteria of Good Disease Management of Diabetes established by the Swiss Society of Endocrinology and Diabetology.
Christ E, Czock A, Renström F, Ammeter T, Ebrahimi F, Zechmann S, Kutz A, Diem P, Häuptle C, Brändle M. Evaluation of type 2 diabetes care management in nine primary care practices before and after implementation of the Criteria of Good Disease Management of Diabetes established by the Swiss Society of Endocrinology and Diabetology. Swiss Med Wkly 2022; 152:w30197.
Jul 26, 2022Evaluation of type 2 diabetes care management in nine primary care practices before and after implementation of the Criteria of Good Disease Management of Diabetes established by the Swiss Society of Endocrinology and Diabetology.
Jul 26, 2022Swiss Med Wkly 2022; 152:w30197
Christ Emanuel, Czock Astrid, Renström Frida, Ammeter Tamara, Ebrahimi Fahim, Zechmann Stefan, Kutz Alexander, Diem Peter, Häuptle Christian, Brändle Michael